Login / Signup

Nirmatrelvir/ritonavir: real world drug-drug interaction management experience.

Shahid BukhariStephen HughesNabeela MughalLuke Sp MooreGary DaviesAdrian Varghas-ZhangMegan NgZekiye KaragozluMarta Boffito
Published in: Expert review of anti-infective therapy (2024)
This highlights the need to maintain and develop pathways for clinical pharmacology expertise in COVID-19 management.
Keyphrases
  • coronavirus disease
  • sars cov
  • emergency department
  • adverse drug
  • drug induced
  • antiretroviral therapy